Nucleus Research Q2 2021 Equity Snapshot: Ceridian

Growing workforce, partnerships position Ceridian to outperform market segment

MIAMI--(BUSINESS WIRE)--Nucleus Research, an independent research firm providing ROI-focused technology research services to both vendors and consumers, has published its Q2 2021 Equity Snapshot for human capital management solutions provider Ceridian.

The Equity Snapshot notes Ceridian is well-positioned for growth in the next 12-18 months due in large part to the workforce returning to a pre-pandemic state, as well as several notable partnerships and acquisitions. In fact, Ceridian just announced an agreement to acquire Toronto-based Ideal, a startup offering hiring and employee management software. These partnerships and acquisitions continue to help Ceridian grow its global presence with enterprise organizations.

“Growth for Ceridian last quarter was slower than expected,” notes Research Manager Trevor White. “However, Ceridian is poised to be an important vendor of HCM solutions as the workforce normalizes and the economy expands – especially in the retail and hospitality industries.”

White also notes in the Equity Snapshot that Ceridian’s competitive price point makes it an ideal investment for users, but the company faces growing competition. Specifically, UKG’s integration of legacy Kronos WFM and UltiPro HCM “offers direct competition to Ceridian’s target customers.”

Nucleus Research listed Ceridian as a “Leader” in both its 2021 HCM Value Matrix and its 2021 WFM Value Matrix.

To download the full Q2 2021 Equity Snapshot for Ceridian, click here.

About Nucleus Research

Nucleus Research is a global provider of investigative, case-based technology research and advisory services. The company’s ROI-focused research approach provides unique insight into the actual results technology solutions deliver, allowing organizations to cut through marketing hype to understand real operational value and select or renew the best technology solution for their environment. For more information, visit NucleusResearch.com.